- A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy
- A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies.
- A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
- A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy
- A Study to Assess the Clinical Validity of Konectom™ in Adults Living With Neuromuscular Disorders
- A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy
- A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
- A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)
- A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).
- A Study to Evaluate Higher Dose (HD) Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Previously Treated With Risdiplam
- A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Ambulatory Children With Spinal Muscular Atrophy
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) Given by Mouth in Healthy Volunteers
- A Trial of Hydroxyurea in Spinal Muscular Atrophy
- Adults With SMA Treated With Nusinersen
- An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)
- An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246)
- An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701)
- An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy
- An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
- AveXis Managed Access Program Cohort for Access to AVXS-101
- Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor
- Clinical Study of Spinal Muscular Atrophy
- Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA)
- COMMAND Early Feasibility Study (EFS)
- Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy
- Effects of Power Mobility on Young Children With Severe Motor Impairments
- Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions
- Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy
- Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)
- Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.
- European Registry of Patients With Infantile-onset Spinal Muscular Atrophy
- Evaluation of the Muscle Strength and Motor Ability in Children With Spinal Muscle Atrophy(SMA) Treated With Valproic Acid
- Evaluation of Therapeutic Response in Spinal Muscular Atrophy Using Multispectral Optoacoustic Tomography (MSOT) and Magnetic Resonance Imaging (MRI)
- Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)
- Exploratory Study of Respiratory Bacterial Infections or Superinfections and Colonizations in Patients With Spinal Muscular Atrophy Under NIV
- Flu Vaccine Study in Neuromuscular Patients 2011
- Hippotherapy in Children With Spinal Muscular Atrophy
- Holter of Movement in Patients With SMA Undergoing Treatment.
- Identification of a Biomarker Associated With Cis-duplication of the SMN1 Gene
- Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
- Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration
- Long Term Trajectories of SMA Patients Receiving or Not Disease-modifying Treatments
- Long-term Follow-Up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
- Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
- MAP THE SMA: a Machine-learning Based Algorithm to Predict THErapeutic Response in Spinal Muscular Atrophy
- Measuring Levels of SMN in Blood Samples of SMA Patients
- Mechanisms and Treatment of Exercise Intolerance and Persistent Fatigue in Spinal Muscular Atrophy
- Mechanisms of Cell Death in Spinal Muscular Atrophy
- Metabolomics of Children With SMA
- Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®
- Motor Unit Number Estimation (MUNE) in Adults With Spinal Muscular Atrophy (SMA)
- Multi-disease Carrier Screening Test Validation
- Myotonometer Intra- and Inter Examiner Reliability on Spinal Muscular Atrophy
- National Registry for Egyptian Pediatric Neuromuscular Diseases
- Natural History of Types 2 and 3 SMA in Taiwan
- Neonatal Spinal Muscular Atrophy (SMA) Screening
- New Imaging Biomarkers for Muscular Diseases – Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy
- Newborn Screening for Spinal Muscular Atrophy
- Newborn Screening for Spinal Muscular Atrophy (SMA) – a Proof of Principle Study Using Anonymised Blood Spots.
- Optimum Insufflation Capacity in NMD
- Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
- Personalized Medicine for SMA: a Translational Project
- Phase II Study of Leuprolide and Testosterone for Men With Kennedy’s Disease or Other Motor Neuron Disease
- Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam
- Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2
- Prenatal Carrier Screening for Spinal Muscular Atrophy Among Thai Pregnant Women
- Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy
- Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices
- Pulmonary Function Test Changes and Respiratory Muscle Strength Trends in Spinal Muscular Atrophy Patients Receiving Nusinersen Treatments
- Quality of Life and Participation of the Adult With Spinal Muscular Atrophy in France
- Quantification of Motor Function in Infants With Spinal Muscular Atrophy Treated With Innovative Therapies
- Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System
- Reciprocating Gait Orthoses for Paraplegia Patients
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Reliability and Validity of the ACTIVE-mini for Quantifying Movement in Infants With Spinal Muscular Atrophy
- Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
- Respiratory Muscle Training in Patients With Spinal Muscular Atrophy (SMA).
- Responsiveness and Validation Study of MFM-20 in SMA Patients Treated With Nusinersen
- Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen
- Risdiplam in Patients With Spinal Muscular Atrophy Previously Treated With Nusinersen
- Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)
- Schulze Muscular Dystrophy Ability Clinical Study
- Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
- SMN Copy Number Distribution in Mali, West Africa
- STENTRODE™ WITH THOUGHT CONTROLLED DIGITAL SWITCH: An Early Feasibility Study (EFS) of the Safety of an Endovascular Motor Neuroprosthesis (MNP) Device in Participants With Severe Upper Limb Impairment.
- Study of Feasibility to Reliably Measure Functional Abilities’ Changes in Nonambulant Neuromuscular Patients Without Trial Site Visiting
- Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy
- Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
- Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms)
- Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL)
- Sun May Arise on SMA : Newborn Screening of SMA in Belgium
- Ultrasound-assisted or Landmark-based Intrathecal Administration of Nusinersen in Adult Patients With Spinal Muscular Atrophy (The EchoSpin Study)
- Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
- Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
- Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
- Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Participants With Spinal Muscular Atrophy
- WREX Outcome Study
Clinical Trials
- A Study of CK-2127107 in Patients With Spinal Muscular Atrophy
- Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)
- Effect of Nusinersen on Adults With Spinal Muscular Atrophy
- Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy
- Fat and Glucose Metabolism in Fed and Fasted State in Patients With Low Skeletal Muscle Mass
- Spinal Muscular Atrophy and Cardiac Autonomic Function
- Aerobic Training in Patients With Spinal Muscular Atrophy Type III
- An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
- Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
- Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX
- Low Interventional Pilot Study to Assess Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders
- Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
- Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
- Phase 3 Active Treatment Trial to Evaluate the Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Who Are Being Treated With Nusinersen or Risdiplam
- Pompe & Pain – Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease
- Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
- Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
- SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4
- Spinal Cord Stimulation in Spinal Muscular Atrophy
- Spinraza in Adult Spinal Muscular Atrophy
- The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy
- Wearable Technology to Assess Gait Function in SMA and DMD
- Whole Body Vibration Therapy in Children With Spinal Muscular Atrophy
- A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
- Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD – BIGPRO Study Astrocytes
- Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
- Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3
- Clinical Trial Readiness for SCA1 and SCA3
- Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3
- Hong Kong Spinocerebellar Ataxias Registry
- Identification of Biomarkers in Spinocerebellar Ataxia 3
- Machado-Joseph Disease in Israel
- Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
- Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD
- Neuropsychiatry and Cognition in SCA3/MJD
- Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
- Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
- Repetitive Transcranial Magnetic Stimulation in SCA3 Patients
- Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
- STRIDES – a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
- Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
- Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia
- An Open Pilot Trial of BHV-4157
- Dalfampridine and Gait in Spinocerebellar Ataxias
- Instrumented Data Exchange for Ataxia Study
- Laryngeal Adaptation for Speech and Swallowing
- Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
- Parkinsonism in Spinocerebellar Ataxia Type 6
- The EUROSCA Natural History Study
- Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia
- An Observational Study in Patients With Unexplained Splenomegaly
- Biomarker for Farber Disease (BioFarber)
- Biomarker for Gaucher Disease: BioGaucher (BioGaucher)
- Biomarker for Sly Disease (MPS VII) (BioSly)
- CINC424A2X01B Rollover Protocol
- Estimation of Spleen by Residents With VScan
- Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination
- Incentive Spirometry and Upper Abdominal Laparoscopic Surgery
- Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
- Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
- Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma
- PREDIGA 2: Spanish Acronym of “Educational and Diagnostic Project for Gaucher and ASMD”
- Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
- Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
- Spleen Size in Peripheral Blood Stem Cell Donors
- Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
- The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department
- Ultrasound Estimation of Spleen Size
- 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis
- A Clinical Study to Evaluate the Efficacy of Biologics in SpA
- A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis
- A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis
- A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
- A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)
- A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
- A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis
- A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis
- A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis
- A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis
- A Study of KHK4827 in Subjects With Axial Spondyloarthritis (axSpA)
- A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
- A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis
- A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
- A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
- A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis
- A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
- A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis
- A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
- A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
- A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis
- A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment
- Adalimumab in Axial Spondyloarthritis (ASIM) – MRI and Biomarkers in Patients With Spondyloarthritis
- Add-on Therapy for Axial Spondyloarthritis
- Advanced Sensor Based Functional ASsessmenTs in Axial Spondyloarthritis
- Analysis of DNA Methylation in Spondyloarthritis
- Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy
- Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
- AScalate: Treat-to-target in Axial Spondyloarthritis
- Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)
- Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis
- Benepali® PEN Patient Satisfaction Survey
- Biobank for Inflammatory Chronic Diseases and Osteoporosis
- Biologic National Registry
- Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis
- Biologic Treatment Registry Across Canada
- Biomarkers in Early-stage Spondyloarthritis
- Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism
- Burst Biologics Spinal Fusion Registry
- Cardiovascular Risk and Chronic Inflammatory Rheumatism
- Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI
- Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
- Cervical Stabilization Exercises in Patients With Spondyloarthritis
- Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
- Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy
- Chronic Inflammatory Disease, Lifestyle and Risk of Disease
- Chronic Inflammatory Disease, Lifestyle and Treatment Response
- CLassification of Axial SpondyloarthritiS Inception Cohort
- Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients’ Nails
- Clinical Characteristics of Importance to Outcome in Patients With Spondyloarthritis
- Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA)
- Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis
- Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
- COMorbidities and EDucation in SPondyloArthritis Study
- Comparative Analysis of Two Therapeutic Strategies in Patients With Spondyloarthritis Treated With Anti-tnf Biologics
- Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Spondyloarthritis Patients
- Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
- Confinement and Spondyloarthritis Treatment
- Conservative Versus Surgical Treatment of Native Vertebral Osteomyelitis
- Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis
- CORset Versus OstéoSynthese in Adult Pyogenic Spondylodiscitis
- COVID-19 VaccinE Response in Rheumatology Patients
- Cryotherapy and Doppler in Inflammatory Rheumatic Diseases
- Cytokine Profiles and suPAR in Spondylodiscitis
- Danish Multicenter Study of Adalimumab in Spondyloarthritis
- Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.
- Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED)
- Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
- Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?
- Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
- Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery
- Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis
- Effect of a Low Starch Diet in Patients With Ankylosing Spondylitis
- Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
- Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity
- Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in Spondyloarthritis
- Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
- Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases
- Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar®
- Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis
- Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission
- Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis
- Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis
- Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation
- Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Axial Spondyloarthritis Resistant to Biotherapies
- Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies
- Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics
- Employment and Arthritis: Making it Work
- Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis
- Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
- Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
- Evaluation of a Patient Education Program for Ankylosing Spondylitis
- Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF
- Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy
- Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
- Evolution and Treatments of Chronic Inflammatory Systemic Diseases
- Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment and Response to it
- Exercise Capacity, Cardiovascular Risk Factors and Disease-related Variables in Axial Spondyloarthritis
- Exercise Therapy in Patients With Axial Spondyloarthritis
- Explore the Associations of Behavioral Factors With Treatment Adherence in Axial Spondyloarthritis Patients Treated With Biotherapy.
- Faecal Analyses in Spondyloarthritis Therapy
- Fatigue and Skeletal Muscle Impact in Severe Axial Spondylarthritis
- Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology
- Follow up Patients With Thoracolumbar Spondylodiscitis Surgically Treated by Posterior Approach
- Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
- French Validation of Axial Spondyloarthritis Questionnaires (Val-SpA)
- Genetics of Ankylosing Spondylitis
- Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (MK-8259-038)
- Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
- Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn’s Disease.
- Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
- Imaging Biomarkers in Crohn’s Associated Spondyloarthritis
- Immobilization and Neurological Complications in Patients With Vertebral Osteomyelitis.
- Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort
- Impact of Literacy Level on Patient Education and Health Among People With Arthritis
- Impact of Medical Education of Physician Action 2
- Improved Cardiovascular Health for Patients With Inflammatory Joint Diseases
- Incidence of MRI Sacro-Iliac (SI) Joint Anomalies in Women With Spondyloarthritis (SpA)
- Incidence of MRI Sacro-Iliac Joint Anomalies in Young Women
- Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials
- Inflammatory Arthritis and Tango
- Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)
- Information and Acceptability of Biosimilars
- Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing
- İnvestigation of Central Sensitization Frequency and Related Factors in AxSpa Patients
- Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis?
- Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
- Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis
- Methotrexate in the Treatment of Axial Spondyloarthritis
- Microbiome and Axial Spondyloarthritis
- Monitoring Spondyloarthritis With SpA-Net
- Move Your Spondyl ” Better Live Its Rheumatism With the Physical Activity “
- MRE as a Screening Tool for axSpA in IBD
- Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
- Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis
- Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis
- Nutrition in Rheumatic Diseases
- Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel
- Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients
- PANLAR’s Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors
- Papillomavirus Load in Rheumatic Inflammatory Diseases
- Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis
- Percutaneous Fluoroscopic vs CT Guided Core Needle Biopsy for Spinal Infection and Tumor
- Performance of EOS Imaging System in the Assessment of Spondyloarthritis Structural Changes Compared With Standard Radiography
- Pharmaceutical Intervention and Adherence to bDMARDs in Spondyloarthritis.
- Physiotherapy of Axial Spondyloarthritis
- Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis
- Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes
- PREDICT-SpA – French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and – Experienced Patients
- Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs
- PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis
- Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism
- Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study
- Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
- REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)
- Referral Recommendations for Axial Spondyloarthritis
- Remote Monitoring of Axial Spondyloarthritis
- Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
- Rheumatism and Dietetic: RHUMADIET Study (Food Practices and Beliefs)
- Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh
- Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
- Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA
- Safety, Tolerability and PK of SHR1314 in axSpA
- Sarcopenia in Axial and Peripheral Spondyloarthropathies
- SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
- Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia
- Seric Calprotectine in Spondyloarthritis
- Serologic Profile of SARS CoV2 in Patients With Systemic Diseases
- Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases
- Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients
- SKIPPAIN – Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis
- Socio-economic Determinants for Acceptance and Choice of Biological Treatment
- Study of Adalimumab in Patients With Axial Spondyloarthritis
- Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis
- Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site
- Study of Gut Microbiota in Crohn’s Disease Patients Suffering From Spondylarthritis
- Study of Jitongning Tablet to Treat Spondyloarthritis
- Study of Leukocyte Populations in Patients With Chronic Inflammatory
- Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain
- Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
- Tai Chi in Spondyloarthritis
- Telerehabilitation, Face-to-Face and Home-Based Spinal Stabilization Exercise Training in Patients With Spondyloarthritis
- Terbinafine Treatment of Axial Spondyloarthropathy
- The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides
- The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry
- The Effect of Exercise on Disease Activity and Cardiovascular Risk for Patients With Axial SpondyloArthritis
- The European Robotic Spinal Instrumentation (EUROSPIN) Study
- The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
- The NOR-SWITCH Study
- The Norwegian Drug Monitoring Study
- The Relationship Between Magnetic Resonance Imaging (MRI) Scores and Sensory Testing in Axial Spondyloarthritis
- The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis
- The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA
- The SpACE Study – Small Bowel Crohn’s Disease and Spondyloarthropathies
- The Value of PET/CT in Diagnosing Residual Disease in Patients With Spinal Infection
- TNFalfa Blocking Treatment of Spondylarthropathies
- to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis
- Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
- Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
- Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs
- Treat-to-target With Secukinumab in Axial Spondyloarthritis
- Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
- Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs
- Unguided Sacroiliac Injection: Effect on Refractory Buttock Pain in Patients With Spondyloarthropathies
- Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.
- Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication
- Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
- Video Coaching of Physical Activity in Axial Spondyloarthritis
- A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
- Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
- Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
- Efficacy of Acupuncture in Macular Diseases
- Function and Imaging Assessments for G1961E-associated Stargardt Disease
- Improving Vision in Adults With Macular Degeneration
- Learning Study: Improving Vision in Adults With Macular Degeneration
- Microcurrent Stimulation to Treat Macular Degeneration
- Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease
- Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
- Oral Metformin for Treatment of ABCA4 Retinopathy
- Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
- Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
- Phase 1 Safety Study of ALK-001 in Healthy Volunteers
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
- Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt’s Macular Degeneration
- Phase I/II Study of SAR422459 in Patients With Stargardt’s Macular Degeneration
- Pupil Dynamics and Color Vision for the Detection of Eye Diseases
- Rod and Cone Mediated Function in Retinal Disease
- Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease
- Safety and Efficacy of Emixustat in Stargardt Disease
- Stem Cell Ophthalmology Treatment Study
- Stem Cells Therapy in Degenerative Diseases of the Retina
- Study of STG-001 in Subjects With Stargardt Disease
- Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1
- Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease
- This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
- Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)